Advertisement

The Italian Multicentric Study on Hypertrophic Cardiomyopathy: I. Natural History and Clinical Course of Unselected Patients

  • F. Cecchi
  • I. Olivotto
  • A. Montereggi
  • E. Lazzeroni
  • G. P. Chiriatti
  • L. Beretta
  • E. Giagnoni
  • G. Renosto
  • M. Ciaccheri
  • G. Castelli
  • A. Dolara
  • Italian Study Group on Cardiomyopathies (SPIC)
Conference paper

Abstract

In the past 8 years since the last Florence meeting, four major issues have emerged in the field of hypertrophie cardiomyopathy (HCM), namely genetic testing, pacemaker therapy, epidemiological data and outcome studies from unselected populations [1]. Among these, epidemiologic studies have shown that HCM is more common than previously thought, with a prevalence of about 0.2% [3]. Also, in contrast with what was once thought based on selected tertiary referral center populations [4], the majority of HCM patients in the general population has been shown to be asymptomatic and non-obstructive [1,4]. Further natural history studies are therefore crucial in order to evaluate the clinical outcome and prognosis in unselected HCM populations, and to assess the appropriate strategies for clinical management of the disease. After we reported in 1989 the good clinical outcome of 157 patients with HCM followed at the Careggi Hospital in Florence [5], a multicentric study was set up including a large study group of patients from 5 non-referral institutions in Central and Northern Italy. The aim of our study was to determine the annual mortality rate for cardiovascular causes, the clinical deterioration rate and the occurrence of cardiovascular events in a large unselected population with HCM.

Keywords

Atrial Fibrillation Hypertrophic Cardiomyopathy Nonsustained Ventricular Tachycardia Italian Multicentric Study Ventricular Outflow Obstruction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Spirito P, Seidman CE, McKenna WJ, Maron BJ (1997) The management of hypertrophic cardiomyopathy. N Engl J Med 336:775–785PubMedCrossRefGoogle Scholar
  2. 2.
    Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE (1995) Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation 92:530–533Google Scholar
  3. 3.
    Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE (1987) Hypertrophic cardiomyopathy: Interrelation of clinical manifestations, pathophysiology, and therapy. N Engl J Med 316:780–789 and 844-852PubMedCrossRefGoogle Scholar
  4. 4.
    Cecchi F, Olivotto I, Montereggi A, Santoro G, Dolara A, Maron BJ (1995) Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected population. J Am Coll Cardiol 26:1529–1536PubMedCrossRefGoogle Scholar
  5. 5.
    Cecchi F, Montereggi A, Squillantini G, Zuppiroli A, Dolara A (1990) The natural history and clinical course of hypertrophie cardiomyopathy. In: G Baroldi, F Camerini, JF Goodwin (eds) Advances in Cardiomyopathies. Springer-Verlag, Berlin Heidelberg New York, pp 25–31CrossRefGoogle Scholar
  6. 6.
    Maron BJ, Cecchi F, McKenna WJ (1994) Risk factors and current status of risk stratification profiles for sudden cardiac death in patients with hypertrophie cardiomyopathy. Br Heart J, 72 [Suppl]:S13–18PubMedCrossRefGoogle Scholar
  7. 7.
    Kofflard MJ, Waldstein DJ, Vos J, ten Cate FJ (1993) Prognosis in hypertrophie cardiomyopathy: Long-term follow-up in a large, unselected outpatient population. Am J Cardiol 72:939–943PubMedCrossRefGoogle Scholar
  8. 8.
    Spirito P, Chiarella F, Carratino L, Berisso MZ, Bellotti P, Vecchio C (1989) Clinical course and prognosis of hypertrophie cardiomyopathy in an outpatient population. N Engl J Med 320:749–755PubMedCrossRefGoogle Scholar
  9. 9.
    McKenna WJ, Oakley CM, Krikler DM, Goodwin JF (1985) Improved survival with amiodarone in patients with hypertrophie cardiomyopathy and ventricular tachycardia. Br Heart J 53:412–416PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 1998

Authors and Affiliations

  • F. Cecchi
  • I. Olivotto
  • A. Montereggi
  • E. Lazzeroni
  • G. P. Chiriatti
  • L. Beretta
  • E. Giagnoni
  • G. Renosto
  • M. Ciaccheri
  • G. Castelli
  • A. Dolara
  • Italian Study Group on Cardiomyopathies (SPIC)

There are no affiliations available

Personalised recommendations